Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
ICON Public Limited Company is a diagnostics & research business based in the US. ICON Public Limited Company shares (ICLR) are listed on the NASDAQ and all prices are listed in US Dollars. ICON Public Limited Company employs 16,480 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$223.76|
|52-week range||$168.76 - $241.52|
|50-day moving average||$214.50|
|200-day moving average||$208.02|
|Wall St. target price||$251.42|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$6.86|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||3.66%|
|3 months (2021-04-30)||3.14%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Valuing ICON Public Limited Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ICON Public Limited Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ICON Public Limited Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, ICON Public Limited Company shares trade at around 35x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
ICON Public Limited Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2237. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ICON Public Limited Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ICON Public Limited Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $558.3 million.
The EBITDA is a measure of a ICON Public Limited Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.2 billion|
|Operating margin TTM||15.34%|
|Gross profit TTM||$819.9 million|
|Return on assets TTM||9.5%|
|Return on equity TTM||20.18%|
|Market capitalisation||$19.2 billion|
TTM: trailing 12 months
There are currently 1.1 million ICON Public Limited Company shares held short by investors – that's known as ICON Public Limited Company's "short interest". This figure is 87.1% down from 8.7 million last month.
There are a few different ways that this level of interest in shorting ICON Public Limited Company shares can be evaluated.
ICON Public Limited Company's "short interest ratio" (SIR) is the quantity of ICON Public Limited Company shares currently shorted divided by the average quantity of ICON Public Limited Company shares traded daily (recently around 1.5 million). ICON Public Limited Company's SIR currently stands at 0.77. In other words for every 100,000 ICON Public Limited Company shares traded daily on the market, roughly 770 shares are currently held short.
However ICON Public Limited Company's short interest can also be evaluated against the total number of ICON Public Limited Company shares, or, against the total number of tradable ICON Public Limited Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ICON Public Limited Company's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 ICON Public Limited Company shares in existence, roughly 10 shares are currently held short) or 0.0217% of the tradable shares (for every 100,000 tradable ICON Public Limited Company shares, roughly 22 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ICON Public Limited Company.
Find out more about how you can short ICON Public Limited Company stock.
We're not expecting ICON Public Limited Company to pay a dividend over the next 12 months.
ICON Public Limited Company's shares were split on a 2:1 basis on 12 August 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your ICON Public Limited Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for ICON Public Limited Company shares which in turn could have impacted ICON Public Limited Company's share price.
Over the last 12 months, ICON Public Limited Company's shares have ranged in value from as little as $168.76 up to $241.52. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ICON Public Limited Company's is 0.8422. This would suggest that ICON Public Limited Company's shares are less volatile than average (for this exchange).
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. The company's clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional solutions, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON has an agreement with Evergreen Therapeutics, Inc. to conduct Phase II clinical trial for COVID-19 drug candidate.
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
Everything we know about the RenovoRx IPO, plus information on how to buy in.
Everything we know about the Draganfly IPO, plus information on how to buy in.
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
Everything we know about the Marpai IPO, plus information on how to buy in.
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.